118,900 Shares in Cardinal Health, Inc. $CAH Bought by Ceredex Value Advisors LLC

Ceredex Value Advisors LLC purchased a new position in Cardinal Health, Inc. (NYSE:CAH - Free Report) in the second quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm purchased 118,900 shares of the company's stock, valued at approximately $28,246,000. Ceredex Value Advisors LLC owned 0.05% of Cardinal Health at the end of the most recent quarter.

Several other hedge funds and other institutional investors have also recently bought and sold shares of the stock. Vanguard Group Inc. grew its stake in shares of Cardinal Health by 2.0% in the 4th quarter. Vanguard Group Inc. now owns 31,441,258 shares of the company's stock valued at $6,461,179,000 after buying an additional 617,775 shares during the period. BlackRock Inc. bought a new stake in Cardinal Health in the 2nd quarter valued at about $6,293,115,000. State Street Corp raised its stake in Cardinal Health by 1.8% during the 4th quarter. State Street Corp now owns 12,509,230 shares of the company's stock worth $2,570,647,000 after buying an additional 221,497 shares during the period. Geode Capital Management LLC raised its stake in Cardinal Health by 0.7% during the 4th quarter. Geode Capital Management LLC now owns 6,529,013 shares of the company's stock worth $1,336,750,000 after buying an additional 43,924 shares during the period. Finally, Wellington Management Group LLP boosted its holdings in Cardinal Health by 153.2% in the third quarter. Wellington Management Group LLP now owns 5,804,090 shares of the company's stock worth $911,010,000 after acquiring an additional 3,511,579 shares in the last quarter. 87.17% of the stock is owned by institutional investors.

Insider Activity

In other Cardinal Health news, CEO Stephen M. Mason sold 35,000 shares of Cardinal Health stock in a transaction on Tuesday, August 18th. The shares were sold at an average price of $236.40, for a total transaction of $8,274,000.00. Following the transaction, the chief executive officer directly owned 18,061 shares of the company's stock, valued at $4,269,620.40. The trade was a 65.96% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Also, insider Jessica L. Mayer sold 29,436 shares of the company's stock in a transaction on Tuesday, August 18th. The stock was sold at an average price of $236.19, for a total transaction of $6,952,488.84. Following the completion of the sale, the insider owned 33,076 shares of the company's stock, valued at approximately $7,812,220.44. The trade was a 47.09% decrease in their position. The SEC filing for this sale provides additional information. Over the last ninety days, insiders sold 210,271 shares of company stock worth $49,626,657. Company insiders own 0.12% of the company's stock.

Cardinal Health News Roundup

Here are the key news stories impacting Cardinal Health this week:

• Positive Sentiment: Royal Bank of Canada initiated coverage of Cardinal Health with a “moderate buy” or outperform-equivalent rating. RBC cited the integration of higher-margin services as a potential driver of future earnings outperformance. RBC Capital Starts Cardinal Health at Outperform
• Positive Sentiment: A Zacks analysis identified CAH as a potentially attractive long-term value stock, while recent coverage has highlighted Cardinal Health’s precision-medicine operations and higher-margin services as sources of sustained growth. Why Cardinal Health Is a Top Value Stock for the Long-Term
• Neutral Sentiment: Brokerages continue to assign Cardinal Health a consensus “moderate buy” rating. The constructive view is tempered by valuation and questions about the sustainability of recent earnings gains.
• Negative Sentiment: Multiple executives and insiders sold shares around $235–$237. Chief Executive Officer Jason Hollar sold a combined 124,529 shares worth approximately $29.4 million, while CEO Deborah Weitzman sold about $1.7 million. Other insider sales included Chief Accounting Officer Mary Scherer and executives Michelle Greene, Jessica Mayer, and Stephen Mason. The transactions substantially reduced several executives’ holdings and may signal that insiders are taking profits after the stock’s strong rally. Cardinal Health Insider Sale Filing
• Negative Sentiment: Although Cardinal Health reported adjusted quarterly EPS of $2.91, well above the $2.42 consensus, an analysis noted that a significant portion of the earnings improvement came from a one-time tariff refund. That raises concerns about the durability of the earnings beat and may be contributing to the weaker stock performance. Cardinal Health Earnings Analysis

Wall Street Analyst Weigh In

A number of equities research analysts have commented on CAH shares. Citigroup raised their price objective on Cardinal Health from $265.00 to $280.00 and gave the company a "buy" rating in a research note on Wednesday, August 12th. Mizuho increased their target price on Cardinal Health from $240.00 to $250.00 and gave the stock an "outperform" rating in a report on Wednesday, August 12th. Barclays increased their target price on Cardinal Health from $258.00 to $275.00 and gave the stock an "overweight" rating in a report on Thursday, August 13th. TD Cowen boosted their price target on shares of Cardinal Health from $275.00 to $280.00 and gave the company a "buy" rating in a research note on Thursday, August 13th. Finally, UBS Group upped their price objective on shares of Cardinal Health from $274.00 to $280.00 and gave the stock a "buy" rating in a report on Wednesday, August 12th. Sixteen research analysts have rated the stock with a Buy rating and three have issued a Hold rating to the company. According to data from MarketBeat.com, the stock currently has an average rating of "Moderate Buy" and an average target price of $266.56.

Cardinal Health Stock Performance

Shares of CAH opened at $228.95 on Friday. The firm has a market capitalization of $53.25 billion, a P/E ratio of 31.67, a P/E/G ratio of 1.26 and a beta of 0.49. Cardinal Health, Inc. has a 52 week low of $145.87 and a 52 week high of $258.30. The stock has a 50 day moving average price of $231.91 and a two-hundred day moving average price of $217.78.

Cardinal Health (NYSE:CAH - Get Free Report) last posted its earnings results on Tuesday, August 11th. The company reported $2.91 earnings per share for the quarter, beating analysts' consensus estimates of $2.42 by $0.49. The company had revenue of $63.67 billion for the quarter, compared to analyst estimates of $65.15 billion. Cardinal Health had a negative return on equity of 98.53% and a net margin of 0.67%.The company's revenue for the quarter was up 5.8% on a year-over-year basis. During the same quarter last year, the company earned $2.08 earnings per share. Cardinal Health has set its FY 2027 guidance at 12.400-12.600 EPS. On average, equities analysts forecast that Cardinal Health, Inc. will post 12.54 earnings per share for the current year.

Cardinal Health Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Thursday, October 15th. Shareholders of record on Thursday, October 1st will be paid a dividend of $0.5158 per share. The ex-dividend date is Thursday, October 1st. This represents a $2.06 annualized dividend and a yield of 0.9%. Cardinal Health's dividend payout ratio (DPR) is 28.49%.

Cardinal Health Profile

Cardinal Health is a multinational healthcare services and products company headquartered in Dublin, Ohio. Tracing its roots to the early 1970s, the company has grown into a major provider of supply chain and distribution services for the healthcare sector. Cardinal Health operates across a range of service lines that support hospitals, health systems, pharmacies, physician offices and clinical laboratories.

The company's core activities include the wholesale distribution of branded and generic pharmaceuticals, the supply and distribution of medical-surgical products, and the provision of logistics and inventory management solutions.

Want to see what other hedge funds are holding CAH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Cardinal Health, Inc. (NYSE:CAH - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat

Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

Add As Preferred Source